AnyTV Bureau, New Delhi.
Published by: Yogesh Sahu
Updated Sat, 26 Feb 2022 06:53 AM IST
Summary
BGR-34 was discovered by the scientists of Council of Scientific and Industrial Research (CSIR) Lucknow based laboratory CIMAP and NBRI a short while back, which has so far received international appreciation from many countries. Last year, Union AYUSH Minister Sarbananda Sonowal had also told that it has been made available to patients after testing for standardization, verification and safety.
hear the news
Expansion
According to the information, researchers of Chitkara University of Punjab recently conducted a study on 100 diabetics, which was published prominently in the Serbian Journal of Experimental and Clinical Research. Some patients were given sitagliptin and some without BGR-34. After this, after analyzing the changes in the patients after four, eight and then 12 weeks, it was found that this drug of CSIR controls the disease in four weeks.
BGR-34 was discovered by the scientists of Council of Scientific and Industrial Research (CSIR) Lucknow based laboratory CIMAP and NBRI a short while back, which has so far received international appreciation from many countries. Last year, Union AYUSH Minister Sarbananda Sonowal had also told that it has been made available to patients after testing for standardization, verification and safety.
HbA1c went down like this
In the study, the researchers found that the baseline value of glycated hemoglobin (HbA1c) was 8.499 percent, but after four weeks in patients taking BGR-34, this value was recorded at 8.061 percent. After this, when the condition of the patients was seen in the eighth and 12th week, then the same values were found to be 6.56 and 6.27 respectively. Similarly, in the random sugar test, the average sugar of the patients came down from 250 to 114 mg / dl. Whereas, empty stomach sugar dropped from 176 to 74 at 12 weeks and from 216 to 87 mg/dL after a meal.
Even the highest risk in the epidemic
According to scientists, the high risk of virus in the corona epidemic is being seen in diabetics. In such a situation, appeals are also being made to these patients to adopt covid vigilance behavior along with continuous monitoring and treatment. Even after the recent COVID vaccination, infection is being seen from moderate to severe in such patients. Therefore, it is very important to take care of already sick patients.